Steve Whitelock CChem FRSC
Steve began his career as an R&D analytical development scientist. He continued his extensive career within the pharmaceutical R&D environment attaining the position of Director of Product Development for small molecules and was responsible for all CMC aspects of drug substance and drug product development, including authoring the quality sections of regulatory submissions. He moved on from the pharmaceutical industry to become a consultant offering CMC project management services and subject matter expertise in product development and analytical chemistry.
Steve is adept at managing local, EU, global and Alliance CMC projects ensuring appropriate engagement with key stakeholders and cross functional representatives to achieve common objectives. He has broad technical and scientific reach, able to support all CMC activities from pre-clinical phase through to commercialisation.
Steve has executed global & European in-house and outsourced drug development projects and product projects across drug delivery platforms ensuring technical success of oral solid dose (immediate and sustained release), transdermal, parenteral, and oral mucosal thin film products.